Diversified Energy Company plc
SC 13G – Schedule filed to report acquisition of beneficial ownership[...]
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor)[...]
Transporeon's Latest Report Reveals Shipper and Carrier Perspectives on[...]
03/27/2024 | Press release | Distributed by Public on 03/27/2024 04:28
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact